These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29535375)

  • 21. Neurochemical Characterization of PSA-NCAM
    Murray HC; Swanson MEV; Dieriks BV; Turner C; Faull RLM; Curtis MA
    Neuroscience; 2018 Feb; 372():289-303. PubMed ID: 29429526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperexcitability in combined entorhinal/hippocampal slices of adult rat after exposure to brain-derived neurotrophic factor.
    Scharfman HE
    J Neurophysiol; 1997 Aug; 78(2):1082-95. PubMed ID: 9307136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro validation of effects of BDNF-expressing mesenchymal stem cells on neurodegeneration in primary cultured neurons of APP/PS1 mice.
    Song MS; Learman CR; Ahn KC; Baker GB; Kippe J; Field EM; Dunbar GL
    Neuroscience; 2015 Oct; 307():37-50. PubMed ID: 26297896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of neurotrophins BDNF and NT-3, and their receptors in rat brain after administration of antipsychotic and psychotrophic agents.
    Lindén AM; Väisänen J; Lakso M; Nawa H; Wong G; Castrén E
    J Mol Neurosci; 2000; 14(1-2):27-37. PubMed ID: 10854034
    [TBL] [Abstract][Full Text] [Related]  

  • 25. AAV-mediated gene delivery of BDNF or GDNF is neuroprotective in a model of Huntington disease.
    Kells AP; Fong DM; Dragunow M; During MJ; Young D; Connor B
    Mol Ther; 2004 May; 9(5):682-8. PubMed ID: 15120329
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Entorhinal volume, aerobic fitness, and recognition memory in healthy young adults: A voxel-based morphometry study.
    Whiteman AS; Young DE; Budson AE; Stern CE; Schon K
    Neuroimage; 2016 Feb; 126():229-38. PubMed ID: 26631814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease.
    Narisawa-Saito M; Wakabayashi K; Tsuji S; Takahashi H; Nawa H
    Neuroreport; 1996 Nov; 7(18):2925-8. PubMed ID: 9116211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Automated segmentation tool for brain infusions.
    Rosenbluth KH; Gimenez F; Kells AP; Salegio EA; Mittermeyer GM; Modera K; Kohal A; Bankiewicz KS
    PLoS One; 2013; 8(6):e64452. PubMed ID: 23755125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal excitability and spontaneous synaptic transmission in the entorhinal cortex of BDNF heterozygous mice.
    Abidin İ; Aydin-Abidin S; Mittmann T
    Neurosci Lett; 2019 Jan; 690():69-75. PubMed ID: 30316983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase advance of the light-dark cycle stimulates production of BDNF, but not of other neurotrophins, in the adult rat cerebral cortex: association with the activation of CREB.
    Katoh-Semba R; Tsuzuki M; Miyazaki N; Matsuda M; Nakagawa C; Ichisaka S; Sudo K; Kitajima S; Hamatake M; Hata Y; Nagata K
    J Neurochem; 2008 Sep; 106(5):2131-42. PubMed ID: 18636983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion.
    Lonser RR; Walbridge S; Garmestani K; Butman JA; Walters HA; Vortmeyer AO; Morrison PF; Brechbiel MW; Oldfield EH
    J Neurosurg; 2002 Oct; 97(4):905-13. PubMed ID: 12405380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspects of excitatory/inhibitory synapses in multiple brain regions are correlated with levels of brain-derived neurotrophic factor/neurotrophin-3.
    Shinoda Y; Sadakata T; Yagishita K; Kinameri E; Katoh-Semba R; Sano Y; Furuichi T
    Biochem Biophys Res Commun; 2019 Feb; 509(2):429-434. PubMed ID: 30594389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Convection-enhanced delivery of AAV2 in white matter--a novel method for gene delivery to cerebral cortex.
    Barua NU; Woolley M; Bienemann AS; Johnson D; Wyatt MJ; Irving C; Lewis O; Castrique E; Gill SS
    J Neurosci Methods; 2013 Oct; 220(1):1-8. PubMed ID: 23988614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peptide immunoreactivity in aged rat cortex and hippocampus as a function of memory and BDNF infusion.
    Croll SD; Chesnutt CR; Greene NA; Lindsay RM; Wiegand SJ
    Pharmacol Biochem Behav; 1999 Nov; 64(3):625-35. PubMed ID: 10548280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease.
    Chin J; Massaro CM; Palop JJ; Thwin MT; Yu GQ; Bien-Ly N; Bender A; Mucke L
    J Neurosci; 2007 Mar; 27(11):2727-33. PubMed ID: 17360894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice.
    Uchida K; Nakajima H; Hirai T; Yayama T; Chen K; Guerrero AR; Johnson WE; Baba H
    Spine (Phila Pa 1976); 2012 Dec; 37(26):2125-35. PubMed ID: 22648027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional Depletion of Hippocampal Brain-Derived Neurotrophic Factor Exacerbates Neuropathology in a Mouse Model of Alzheimer's Disease.
    Braun DJ; Kalinin S; Feinstein DL
    ASN Neuro; 2017; 9(2):1759091417696161. PubMed ID: 28266222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain-derived neurotrophic factor, nerve growth and neurotrophin-3 selected regions of the rat brain following kainic acid-induced seizure activity.
    Katoh-Semba R; Takeuchi IK; Inaguma Y; Ito H; Kato K
    Neurosci Res; 1999 Oct; 35(1):19-29. PubMed ID: 10555160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neocortical and hippocampal glucose hypometabolism following neurotoxic lesions of the entorhinal and perirhinal cortices in the non-human primate as shown by PET. Implications for Alzheimer's disease.
    Meguro K; Blaizot X; Kondoh Y; Le Mestric C; Baron JC; Chavoix C
    Brain; 1999 Aug; 122 ( Pt 8)():1519-31. PubMed ID: 10430835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: support for nigral targeting in Parkinson's disease.
    Bartus RT; Brown L; Wilson A; Kruegel B; Siffert J; Johnson EM; Kordower JH; Herzog CD
    Neurobiol Dis; 2011 Oct; 44(1):38-52. PubMed ID: 21704161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.